Sanofi to Drop Eczema Drug Amid Review of Pipeline Under New CEO
The drugmaker said efficacy and safety data didn’t support further development of the drug, amlitelimab, for atopic dermatitis.
Connecting Global Economies
Flash News
Spain, France wildfires force tens of thousands to evacuate
Pentagon removed four from official Iran war death toll
Best Luxury Beauty Exclusives You Can Only Get During the Nordstrom Sale
Poll shows new problem for GOP: Americans think gas prices are worse than they are
Out with World Cup, in with L.A. Olympics: Casey Wasserman braces for a ‘fast’ two years
Outside In | Trump’s latest tariff tantrum unlikely to end well for the US
Trump considering ‘massive attack’ on Iran, Tehran threatens UK
Pete Davidson in Tommy Karate Movie: See Unrecognizable Actor
After World Cup heartbreak, what’s left for Lionel Messi to win?
Sanofi to Drop Eczema Drug Amid Review of Pipeline Under New CEO
Friday, July 24, 2026